Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-07-002173
Filing Date
2007-04-10
Accepted
2007-04-10 17:29:29
Documents
10
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 EPIX PHARMACEUTICALS, INC. b63190epe10vk.htm 10-K 1982419
2 EX-10.52 FIRST AMENDMENT TO LICENSE AGREEMENT BETWEEN AMGEN INC. AND THE COMPANY b63190epexv10w52.txt EX-10.52 5263
3 EX-12.1 RATIO OF EARNINGS TO FIXED CHARGES b63190epexv12w1.htm EX-12.1 14460
4 EX-21.1 SUBSIDIARIES OF THE COMPANY b63190epexv21w1.htm EX-21.1 2272
5 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM b63190epexv23w1.htm EX-23.1 1895
6 EX-31.1 SECTION 302 CERTIFICATION OF CEO b63190epexv31w1.htm EX-31.1 6422
7 EX-31.2 SECTION 302 CERTIFICATION OF CFO b63190epexv31w2.htm EX-31.2 6338
8 EX-32 SECTION 906 CERTIFICATION OF CEO & CFO b63190epexv32.htm EX-32 3537
9 GRAPHIC b63190epb6319001.gif GRAPHIC 15905
10 GRAPHIC b63190epb6319002.gif GRAPHIC 9507
  Complete submission text file 0000950135-07-002173.txt   2059369
Mailing Address 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address 4 MAGUIRE ROAD LEXINGTON MA 02421 6172506000
EPIX Pharmaceuticals, Inc. (Filer) CIK: 0001027702 (see all company filings)

EIN.: 043030815 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21863 | Film No.: 07759660
SIC: 2834 Pharmaceutical Preparations